Get started
Author

Victor Pashkov

Observed name: Pashkov, Victor
OpenAlex ID: A5065713709
Dual Checkpoint Aptamer Immunotherapy: Unveiling Tailored Cancer Treatment Targeting CTLA-4 and NKG2A
2024 · Mohamad Ammar Ayass, Trivendra Tripathi, et al. · Cancers · 16
New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote
2023 · Mohamad Ammar Ayass, Natalya Griko, et al. · Cells · 12
PDF
Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system
2022 · Mohamad Ammar Ayass, Wanying Cao, et al. · PLoS ONE · 9
PDF
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease
2022 · Mohamad Ammar Ayass, Trivendra Tripathi, et al. · Virology Journal · 5
PDF
High-Affinity Neutralizing DNA Aptamers against SARS-CoV-2 Spike Protein Variants
2023 · Mohamad Ammar Ayass, Natalya Griko, et al. · COVID · 3
PDF
AYA22A Aptamers Mitigate Peanut Allergenicity: Insights from Degranulation Assays and Modulating Immune Responses
2024 · Mohamad Ammar Ayass, Trivendra Tripathi, et al. · Allergies · 2
Macrophage-Induced Exacerbation of Nasopharyngeal Inflammatory Lymphocytes in COVID-19 Disease
2023 · Mohamad Ammar Ayass, Trivendra Tripathi, et al. · COVID · 2
PDF
Aptamer-Enhanced Surface Decontamination: A Novel Approach for Neutralizing Peanut Allergens and Preventing Cell-Degranulation
2025 · Mohamad Ammar Ayass, Trivendra Tripathi, et al. · Allergies · 1
Selective Thrombin Modulation by AYA1809002: Stability and On-Demand Reversal of an Exosite I-Targeting Aptamer
2026 · Mohamad Ammar Ayass, Natalya Griko, et al. · Pharmaceuticals
Works count: 10
Citation count: 50
H-index: 4
I10-index: 2
Year
Topic
Type